Mon, September 16, 2024
[ 12:00 AM ] - WOPRAI
Thu, September 5, 2024
[ 12:00 AM ] - WOPRAI
Wed, September 4, 2024
[ 12:00 AM ] - WOPRAI
Mon, August 26, 2024
[ 12:00 AM ] - WOPRAI
Wed, August 21, 2024
[ 12:00 AM ] - WOPRAI
Tue, August 20, 2024
[ 12:00 AM ] - WOPRAI
Thu, August 15, 2024
[ 12:00 AM ] - WOPRAI
Mon, August 5, 2024
[ 12:00 AM ] - WOPRAI
Thu, July 25, 2024
[ 12:00 AM ] - WOPRAI
Mon, July 15, 2024
[ 12:00 AM ] - WOPRAI
Wed, July 3, 2024
[ 12:00 AM ] - WOPRAI
Wed, June 12, 2024
[ 12:00 AM ] - WOPRAI
Tue, May 21, 2024
[ 12:00 AM ] - WOPRAI
Fri, May 3, 2024
[ 12:00 AM ] - WOPRAI
Tue, April 2, 2024
[ 12:00 AM ] - WOPRAI
Tue, March 26, 2024
[ 12:00 AM ] - WOPRAI
Fri, March 22, 2024
[ 12:00 AM ] - WOPRAI
Tue, March 19, 2024
[ 12:00 AM ] - WOPRAI
Tue, February 6, 2024
[ 12:00 AM ] - WOPRAI
Thu, February 1, 2024
[ 12:00 AM ] - WOPRAI
Fri, December 1, 2023
[ 12:00 AM ] - WOPRAI
Mon, November 20, 2023
[ 12:00 AM ] - WOPRAI
Tue, May 2, 2023
[ 12:00 AM ] - WOPRAI
Tue, April 25, 2023
[ 12:00 AM ] - WOPRAI
Mon, April 10, 2023
[ 12:00 AM ] - WOPRAI
Wed, February 8, 2023
[ 12:00 AM ] - WOPRAI
Tue, December 6, 2022
Jessica Fye Upgraded (BNTX) to Hold and Increased Target to $125 on, Sep 16th, 2024
Jessica Fye of JP Morgan, Upgraded "BioNTech SE" (BNTX) to Hold and Increased Target from $91 to $125 on, Sep 16th, 2024.
Jessica has made no other calls on BNTX in the last 4 months.
There are 3 other peers that have a rating on BNTX. Out of the 3 peers that are also analyzing BNTX, 2 agree with Jessica's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Akash Tewari of "Jefferies" Maintained at Hold with Increased Target to $96 on, Friday, September 13th, 2024
- Yaron Werber of "TD Cowen" Maintained at Hold with Decreased Target to $85 on, Tuesday, August 6th, 2024
This is the rating of the analyst that currently disagrees with Jessica
- Emmanuel Papadakis of "Deutsche Bank" Upgraded from Hold to Strong Buy and Held Target at $95 on, Wednesday, August 7th, 2024
Contributing Sources